Canada to start recommending AstraZeneca coronavirus vaccine for seniors over 65: source - CP24 Toronto's Breaking News | Canada News Media
Connect with us

Business

Canada to start recommending AstraZeneca coronavirus vaccine for seniors over 65: source – CP24 Toronto's Breaking News

Published

 on


Canada’s vaccine advisory committee is poised to announce that it will start recommending the AstraZeneca COVID-19 vaccine for those older than 65 years old, a senior government source tells CTV News.

The National Advisory Committee on Immunization (NACI) is expected to confirm that the AstraZeneca vaccine will now be recommended for people over 65 at a news conference Tuesday morning, the source said.

The federal advisory committee had initially recommended that AstraZeneca only be given to those younger than 65 because there was insufficient data about its efficacy for older people.

Quebec had said that it would nonetheless provide the vaccine to older seniors, while other provinces, including Ontario, had said that it would only give it to those under 65.

Speaking with CP24 Monday night, federal Minister of Public Services and Procurement Anita Anand said the NACI guidance is designed to help provinces make decisions about the rollout, but it is up to the provinces to decide for themselves.

“The NACI guidelines are separate and independent from the work I’m doing and indeed from  government,” Anand said. “That’s an independent committee that is making recommendations and the provinces and territories can choose to implement those recommendations in any way they choose.”

Ontario Solicitor-General Sylvia Jones also spoke with CP24 Monday night and said Ontario will not likely change the way it is using AstraZeneca while quantities of the vaccine remain low in the province.

“We’ll look very carefully at the National Advisory Committee on Immunizations recommendations and see if there’s an opportunity where we can expand, but frankly we have a very limited supply of AstraZeneca right now and the 60 to 64 age group that we’re offering it (to) through vaccines (at) pharmacies and primary care is sufficient at this point,” Jones said. “When we get more supplies, then we can look at expanding the age groups.”

A pilot project launched in Ontario last week to distribute the AstraZeneca vaccine to those under 65 years old through pharmacies in three regions. However pharmacies have already said that they are running out of doses.

Canada has pre-ordered 20 million doses of the AstraZeneca vaccine, but it is not yet clear exactly when those doses will arrive.

“Our procurements of AstraZeneca are from primarily our bilateral contract with the company,” Anand said. “We’ll be getting 20 million doses of AstraZeneca from the United States over the second quarter —  that’s just before the month of June ends — and over the third quarter prior to the end of September.”

About 500,000 of the 2 million doses ordered from the Serum Institute of India have already arrived in the country, Anand said.

She said with millions of doses expected to arrive in the country soon, Canada will start seeing a major ramp-up in vaccinations and the goal of offering a vaccine to every Canadian who wants one by September remains “very realistic.”

However she stopped short of saying that the current dosing interval of four months could be shortened or that the September goal could be brought forward.

“It certainly is possible but given the need for caution in a global environment that is incredibly competitive and where supply chains around the world are somewhat volatile – look at our experience earlier in the year when Pfizer decided to retool its plant in Belgium – so my view is that we need to be cautious and what the federal government is going to continue to do is to procure more and more vaccines, accelerate those doses, from one quarter into the next,”Anand said.

NACI Chair Dr. Caroline Quach told The Canadian Press last week that the committee was analyzing new evidence about how well the AstraZeneca vaccine worked in seniors and that it would provide an update soon.

The changing guidance on who should get the shot comes at the same time that federal officials try to reassure Canadians that the vaccine is safe. A number of European countries have recently paused their use of the AstraZeneca vaccine over concerns that it may have been linked to some reports of blood clots. Canadian officials have said there’s no evidence to suggest a link so far and have maintained the vaccine is safe.

A statement by the company Monday also said that there is no evidence linking the vaccine to clots so far.

“A careful review of all available safety data of more than 17 million people vaccinated in the European Union (EU) and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” AstraZeneca said in an email to CTV News.

–          With files from The Canadian Press and CTV News

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Dollarama keeping an eye on competitors as Loblaw launches new ultra-discount chain

Published

 on

 

Dollarama Inc.’s food aisles may have expanded far beyond sweet treats or piles of gum by the checkout counter in recent years, but its chief executive maintains his company is “not in the grocery business,” even if it’s keeping an eye on the sector.

“It’s just one small part of our store,” Neil Rossy told analysts on a Wednesday call, where he was questioned about the company’s food merchandise and rivals playing in the same space.

“We will keep an eye on all retailers — like all retailers keep an eye on us — to make sure that we’re competitive and we understand what’s out there.”

Over the last decade and as consumers have more recently sought deals, Dollarama’s food merchandise has expanded to include bread and pantry staples like cereal, rice and pasta sold at prices on par or below supermarkets.

However, the competition in the discount segment of the market Dollarama operates in intensified recently when the country’s biggest grocery chain began piloting a new ultra-discount store.

The No Name stores being tested by Loblaw Cos. Ltd. in Windsor, St. Catharines and Brockville, Ont., are billed as 20 per cent cheaper than discount retail competitors including No Frills. The grocery giant is able to offer such cost savings by relying on a smaller store footprint, fewer chilled products and a hearty range of No Name merchandise.

Though Rossy brushed off notions that his company is a supermarket challenger, grocers aren’t off his radar.

“All retailers in Canada are realistic about the fact that everyone is everyone’s competition on any given item or category,” he said.

Rossy declined to reveal how much of the chain’s sales would overlap with Loblaw or the food category, arguing the vast variety of items Dollarama sells is its strength rather than its grocery products alone.

“What makes Dollarama Dollarama is a very wide assortment of different departments that somewhat represent the old five-and-dime local convenience store,” he said.

The breadth of Dollarama’s offerings helped carry the company to a second-quarter profit of $285.9 million, up from $245.8 million in the same quarter last year as its sales rose 7.4 per cent.

The retailer said Wednesday the profit amounted to $1.02 per diluted share for the 13-week period ended July 28, up from 86 cents per diluted share a year earlier.

The period the quarter covers includes the start of summer, when Rossy said the weather was “terrible.”

“The weather got slightly better towards the end of the summer and our sales certainly increased, but not enough to make up for the season’s horrible start,” he said.

Sales totalled $1.56 billion for the quarter, up from $1.46 billion in the same quarter last year.

Comparable store sales, a key metric for retailers, increased 4.7 per cent, while the average transaction was down2.2 per cent and traffic was up seven per cent, RBC analyst Irene Nattel pointed out.

She told investors in a note that the numbers reflect “solid demand as cautious consumers focus on core consumables and everyday essentials.”

Analysts have attributed such behaviour to interest rates that have been slow to drop and high prices of key consumer goods, which are weighing on household budgets.

To cope, many Canadians have spent more time seeking deals, trading down to more affordable brands and forgoing small luxuries they would treat themselves to in better economic times.

“When people feel squeezed, they tend to shy away from discretionary, focus on the basics,” Rossy said. “When people are feeling good about their wallet, they tend to be more lax about the basics and more willing to spend on discretionary.”

The current economic situation has drawn in not just the average Canadian looking to save a buck or two, but also wealthier consumers.

“When the entire economy is feeling slightly squeezed, we get more consumers who might not have to or want to shop at a Dollarama generally or who enjoy shopping at a Dollarama but have the luxury of not having to worry about the price in some other store that they happen to be standing in that has those goods,” Rossy said.

“Well, when times are tougher, they’ll consider the extra five minutes to go to the store next door.”

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:DOL)

Source link

Continue Reading

Business

U.S. regulator fines TD Bank US$28M for faulty consumer reports

Published

 on

 

TORONTO – The U.S. Consumer Financial Protection Bureau has ordered TD Bank Group to pay US$28 million for repeatedly sharing inaccurate, negative information about its customers to consumer reporting companies.

The agency says TD has to pay US$7.76 million in total to tens of thousands of victims of its illegal actions, along with a US$20 million civil penalty.

It says TD shared information that contained systemic errors about credit card and bank deposit accounts to consumer reporting companies, which can include credit reports as well as screening reports for tenants and employees and other background checks.

CFPB director Rohit Chopra says in a statement that TD threatened the consumer reports of customers with fraudulent information then “barely lifted a finger to fix it,” and that regulators will need to “focus major attention” on TD Bank to change its course.

TD says in a statement it self-identified these issues and proactively worked to improve its practices, and that it is committed to delivering on its responsibilities to its customers.

The bank also faces scrutiny in the U.S. over its anti-money laundering program where it expects to pay more than US$3 billion in monetary penalties to resolve.

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version